The paradoxical role of IL-17 in atherosclerosis

被引：71
作者：
Gong, Fangchen [1 ]
Liu, Zhengxia [1 ]
Liu, Jingning [1 ]
Zhou, Ping [1 ]
Liu, Ying [1 ]
Lu, Xiang [1 ]
机构：
[1] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 2, Nanjing 210029, Jiangsu, Peoples R China
来源：
CELLULAR IMMUNOLOGY | 2015年 / 297卷 / 01期
基金：
美国国家科学基金会;
关键词：
Atherosclerosis; IL-17; Coronary artery disease; Immunity; DELTA-T-CELLS; ROR-GAMMA-T; SMOOTH-MUSCLE-CELLS; C-REACTIVE PROTEIN; NF-KAPPA-B; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSES; TH17; CELLS; TNF-ALPHA; DIFFERENTIATION;
D O I：
10.1016/j.cellimm.2015.05.007
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Atherosclerosis is a chronic inflammatory disease mediated by innate and adaptive immune responses. In recent years, CD4(+) T cells (Th1, Th2, Treg, and Th17) have been increasingly studied for their role in atherosclerosis pathophysiology, atheroma stability, plaque rupture, and life-threatening acute coronary syndrome. IL-17, a marker cytokine of Th17 cells, has been reported to be involved in the pathogenesis of rheumatoid arthritis, inflammatory bowel disease, and asthma. However, its role in atherosclerosis has been poorly characterized. This article provides a comprehensive overview of the role of IL-17 in the development of atherosclerosis and human coronary artery diseases. (C) 2015 Published by Elsevier Inc.
引用
收藏
页码：33 / 39
页数：7
相关论文
共 50 条
  • [41] Barrier immunity and IL-17
    Marks, Benjamin R.
    Craft, Joe
    [J]. SEMINARS IN IMMUNOLOGY, 2009, 21 (03) : 164 - 171
  • [42] IL-17 in the immunopathogenesis of spondyloarthritis
    Taams, Leonie S.
    Steel, Kathryn J. A.
    Srenathan, Ushani
    Burns, Lachrissa A.
    Kirkham, Bruce W.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (08) : 453 - 466
  • [43] IL-17 and HIV pathogenesis
    Campillo-Gimenez, Laure
    Elbim, Carole
    Laforge, Mireille
    Leite-de-Moraes, Maria C.
    Zaunders, John
    Estaquier, Jerome
    [J]. EUROPEAN CYTOKINE NETWORK, 2010, 21 (03) : 222 - 225
  • [44] The significance of Agaricus blazei as an immunomodulator of the level of IL-17 in Balb/C mice with atherosclerosis
    Tontowiputro, Dicky Kurniawan
    Sargowo, Djanggan
    Tjokroprawiro, Askandar
    Rifa'i, Muhaimin
    [J]. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 45 (01) : 1 - 8
  • [45] IL-17 and limits of success
    Omidian, Zahra
    Ahmed, Rizwan
    Giwa, Adebola
    Donner, Thomas
    Hamad, Abdel Rahim A.
    [J]. CELLULAR IMMUNOLOGY, 2019, 339 : 33 - 40
  • [46] IL-17 and Th17 Cells
    Korn, Thomas
    Bettelli, Estelle
    Oukka, Mohamed
    Kuchroo, Vijay K.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 : 485 - 517
  • [47] Cytokines IL-17 and IL-22 in the host response to infection
    Valeri, Maria
    Raffatellu, Manuela
    [J]. PATHOGENS AND DISEASE, 2016, 74 (09):
  • [48] Expression of IL-33 in the epidermis: The mechanism of induction by IL-17
    Meephansan, Jitlada
    Komine, Mayumi
    Tsuda, Hidetoshi
    Karakawa, Masaru
    Tominaga, Shin-ichi
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2013, 71 (02) : 107 - 114
  • [49] The Role of Th17/IL-17 in the Pathogenesis of Primary Nephrotic Syndrome in Children
    Wang, Li
    Li, Qiu
    Wang, Lijia
    Li, Cuicui
    Yang, Haiping
    Wang, Xiaoli
    Tao, Hong
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2013, 37 (4-5) : 332 - 345
  • [50] Novel key cytokines in allergy: IL-17, IL-22
    Eyerich, S.
    Traidl-Hoffmann, C.
    Behrendt, H.
    Cavani, A.
    Schmidt-Weber, C. B.
    Ring, J.
    Eyerich, K.
    [J]. ALLERGOLOGIE, 2011, 34 (07) : 344 - 349
12345